Effect of pharmaceutical formulation on health care expenditures for hypertension: A study of verapamil in a medicaid population

Cramer, 1989, How often is medication taken as prescribed? A novel assessment technique, JAMA, 261, 3273, 10.1001/jama.1989.03420220087032 Cooper, 1982, Intentional prescription nonadherence by the elderly, J Am Geriatr Soc, 30, 329, 10.1111/j.1532-5415.1982.tb05623.x Christensen-Szalanski, 1985, Patient compliance behavior: The effect of time on patient's values of treatment regimens, J Soc Sci Med, 21, 263, 10.1016/0277-9536(85)90100-5 Hammerlund, 1985, The effects of drug counseling and other educational strategies on drug utilization in the elderly, Med Care, 23, 165, 10.1097/00005650-198502000-00007 Eraker, 1984, Understanding and improving patient compliance, Ann Intern Med, 100, 258, 10.7326/0003-4819-100-2-258 Sclar, 1991, Utility of a transdermal delivery system for antihypertensive therapy. Part I & II, Am J Med, 91, 50S, 10.1016/0002-9343(91)90063-4 Sclar, 1992, Effect of health education on the utilization of HMO services: A prospective trial among patients with hypertension, Prim Cardiol, 18, 35 Greenburg, 1984, Overview of patient compliance with medication dosing: A literature review, Clin Ther, 6, 592 The 1988 Joint National Committee, 1988, Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, Arch Intern Med, 148, 1023, 10.1001/archinte.1988.00380050029006 Amery, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial, Lancet, 1, 1349, 10.1016/S0140-6736(85)91783-0 Tuck, 1988, Clinical care of the aging hypertensive patient, J Cardiovasc Pharmacol, 12, S40, 10.1097/00005344-198812081-00010 Staessen, 1988, Antihypertensive drug treatment in elderly hypertensive subjects: Evidence of protection, J Cardiovasc Pharmacol, 12, S33, 10.1097/00005344-198812081-00008 1987, Detection, evaluation, and treatment of hypertension: Final report, Arch Intern Med, 147, 820, 10.1001/archinte.1987.00370050016004 Kannel, 1980, Perspectives on systolic hypertension: The Framingham study, Circulation, 61, 1179, 10.1161/01.CIR.61.6.1179 Anderson, 1982, Therapeutic considerations for elderly hypertensives, Clin Ther, 5, 25 Medical Research Council Working Party, 1985, MRC trial of treatment of mild hypertension: Principal results, BMJ, 291, 97, 10.1136/bmj.291.6488.97 Nonpharmacologic Approaches to the Control of High Blood Pressure, 1986, Final report of the Subcommittee on Nonpharmacologic Therapy of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, 8, 444 Kaplan, 1985, Non-drug treatment of hypertension, Ann Intern Med, 102, 359, 10.7326/0003-4819-102-3-359 Wilber, 1972, Hypertension—a community problem, Am J Med, 52, 653, 10.1016/0002-9343(72)90055-1 Swain, 1981, Influencing adherence among hypertensives, Res Nurs Health, 4, 213, 10.1002/nur.4770040107 Inglehart, 1985, Medical care of the poor: A growing problem, New Engl J Med, 313, 59, 10.1056/NEJM198507043130134 Hammel, 1972, Insights into public assistance medical care expenditures, JAMA, 219, 1739, 10.1001/jama.1972.03190390026007 Meyers, 1981, Measurement of formulary inclusion costs, Hosp Formul, 9, 951 Schweitzer, 1985, The social drug lag: An examination of pharmaceutical approval delays in Medicaid formularies, Soc Sci Med, 21, 1077, 10.1016/0277-9536(85)90163-7 Dranove, 1989, Medicaid drug formulary restrictions, J Law Econ, 33, 143, 10.1086/467172 Grabowski, 1988, Medicaid patients access to new drugs, Health Aff, 7, 102, 10.1377/hlthaff.7.5.102 Moore, 1989 McDonald, 1988, The evolution of current hypertension therapy, Am J Med, 85, 14, 10.1016/0002-9343(88)90344-0 Schumacher, 1991, Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers, Am J Hosp Pharm, 48, 301 1992 1992, 274 Kruse, 1990, Dynamics of drug regimen compliance—Its assessment by micro-processor-based monitoring, Eur J Pharmacol, 38, 561, 10.1007/BF00278582 Rudd, 1990, Improved compliance measures: Applications in an ambulatory hypertensive drug trial, Clin Pharmacol Ther, 48, 676, 10.1038/clpt.1990.211